Clinical Trial Update: Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers [NA]

View source ↗

Summary

A completed clinical trial assessing the interaction potential between dolutegravir and simeprevir in HIV/HCV seronegative volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Dolutegravir (dolutegravir)
• Simeprevir (simeprevir)

Snippet

Sponsor: University of Colorado, Denver | Conditions: HIV, Hepatitis C | NA | Status: COMPLETED | Results posted: 2021-03-17